Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · IEX Real-Time Price · USD
0.470
-0.002 (-0.51%)
Mar 28, 2024, 9:46 AM EDT - Market open

Novo Integrated Sciences Balance Sheet

Millions USD. Fiscal year is Sep - Aug.
Year 20232022202120202019201820172016
Cash & Equivalents
0.422.188.292.072.080.681.90.11
Cash & Cash Equivalents
0.422.188.292.072.080.681.90.11
Cash Growth
-80.89%-73.73%301.08%-0.77%208.37%-64.37%1619.23%-
Receivables
2.522.12.982.322.831.791.52.31
Inventory
1.110.880.3400000
Other Current Assets
0.350.57-0.47-0.1-0.810.10.250.16
Total Current Assets
4.395.7311.134.294.12.573.652.57
Property, Plant & Equipment
7.378.478.613.163.410.40.30.32
Goodwill and Intangibles
23.826.6741.5227.2622.980.60.40
Other Long-Term Assets
000.690.671.781.171.160
Total Long-Term Assets
31.1735.1450.8231.128.172.171.860.32
Total Assets
35.5640.8761.9635.3932.274.745.512.89
Accounts Payable
4.052.281.931.412.062.423.523.87
Current Debt
2.189.695.040.650.510.380.015.03
Other Current Liabilities
1.682.11.50.540.450.540.741.07
Total Current Liabilities
7.914.078.462.63.033.354.279.97
Long-Term Debt
1.763.318.193.223.71.225.530.01
Other Long-Term Liabilities
1.41.451.500000
Total Long-Term Liabilities
3.164.759.693.223.71.225.530.01
Total Liabilities
11.0618.8318.155.826.734.579.89.98
Total Debt
3.941313.233.874.211.615.545.04
Debt Growth
-69.69%-1.77%242.20%-8.17%162.08%-71.01%10.01%-
Retained Earnings
-67.03-53.82-20.97-16.51-11.59-11.2-9.09-8.35
Comprehensive Income
-0.360.560.991.21.141.141.241.28
Shareholders' Equity
24.8222.3143.8629.6225.580.2-4.27-7.08
Net Cash / Debt
-3.52-10.82-4.94-1.8-2.13-0.93-3.65-4.93
Net Cash Per Share
-0.35-3.71-1.99-0.78-0.98-0.45-2.05-2.94
Working Capital
-3.52-8.342.671.691.07-0.78-0.62-7.4
Book Value Per Share
2.447.6617.7112.8611.770.10-2.40-4.22
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).